Search

Your search keyword '"Adetifa I"' showing total 118 results

Search Constraints

Start Over You searched for: Author "Adetifa I" Remove constraint Author: "Adetifa I"
118 results on '"Adetifa I"'

Search Results

1. Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study

3. A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)–Study protocol

6. National tuberculosis prevalence surveys in Africa, 2008–2016: an overview of results and lessons learned

8. Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: repeated cross-sectional surveys 2020-21

9. Seroprevalence of antibodies to SARS-CoV-2 among health care workers in Kenya

10. Molecular Epidemiology, Drug-Resistant Variants, and Therapeutic Implications of Hepatitis B Virus and Hepatitis D Virus Prevalence in Nigeria: A National Study

11. TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults)

12. Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in two Kenyan referral hospitals

15. Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome

16. Upper airways colonisation of Streptococcus pneumoniae in adults aged 60 years and older: A systematic review of prevalence and individual participant data meta-analysis of risk factors

17. Upper airways colonisation of Streptococcus pneumoniae in adults aged 60 years and older:A systematic review of prevalence and individual participant data meta-analysis of risk factors

18. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

19. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016

20. Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015 : A novel analysis from the global burden of disease study 2015

21. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015

22. Setting up data science research in Africa and engagement of stakeholders

30. Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia

31. No proof that BCG protects against M tuberculosis.

32. Effect of BCG vaccination against Mycobacterium tuberculosisinfection in children: systematic review and meta-analysis

33. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016

34. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

35. Correction: A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol.

36. ASEAN's response to mpox: Advancing regional and inter-regional cooperation to manage public health emergencies.

37. Development and Implementation of a Public Health Event Management System, Nigeria, 2018-2024.

38. The impact of sub-national heterogeneities in demography and epidemiology on the introduction of rubella vaccination programs in Nigeria.

39. Performance evaluation of SARS-CoV-2 rapid diagnostic tests in Nigeria: A cross-sectional study.

40. Genomic epidemiology uncovers the timing and origin of the emergence of mpox in humans.

41. Molecular epidemiology of recurrent zoonotic transmission of mpox virus in West Africa.

42. Tungiasis among children in Kenya is associated with poor nutrition status, absenteeism, poor school performance and high impact on quality of life.

43. Epidemiology of influenza in Nigeria: A secondary analysis of the sentinel surveillance data in Nigeria from 2010 - 2020.

44. Mpox (monkeypox) risk and mortality associated with HIV infection: a national case-control study in Nigeria.

45. Schistosomiasis Seroprevalence among Children Aged 0-14 Years in Nigeria, 2018.

46. APOBEC3 deaminase editing in mpox virus as evidence for sustained human transmission since at least 2016.

47. National prevalence and risk factors for tungiasis in Kenya.

48. Distinct monkeypox virus lineages co-circulating in humans before 2022.

49. Mpox neglect and the smallpox niche: a problem for Africa, a problem for the world.

50. Predictors of Lassa fever diagnosis in suspected cases reporting to health facilities in Nigeria.

Catalog

Books, media, physical & digital resources